Studying age-dependent effects in multiple sclerosis

Studying age-dependent effects in multiple sclerosis - SAMS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033246

Enrollment

150

Registered

2024-02-19

Start date

2024-02-27

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35

Interventions

Group 1: Patients = 50 years with a diagnosis of multiple sclerosis undergo the following procedures: - Filling-in of questionnaires - Blood sample - follow-up of questionnaires and blood sample after

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of multiple sclerosis Capacity to consent

Exclusion criteria

Exclusion criteria: No diagnosis of multiple sclerosis / no capacity to consent / age < 50 years

Design outcomes

Primary

Measure	Time frame
Influence of clinical characteristics and biomarkers on disease activity and progression of multiple sclerosis.	—

Countries

Germany

Contacts

Public ContactKatrin Pape

Universitätsmedizin Mainz Klinik und Poliklinik für Neurologie

katrin.pape@unimedizin-mainz.de00496131177156

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026